adenosine monophosphate has been researched along with Respiratory Distress Syndrome in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 13 (86.67) | 2.80 |
| Authors | Studies |
|---|---|
| Blanco, R; Haider, N; Patel, RH; Pella, PM | 1 |
| Anderson, C; Neil, GA; Perlin, DS; Raines, S; Ware, CF; Wilkins, HJ; Zafir-Lavie, I | 1 |
| Cohen, S; Corbett, R; Haczku, A; Hardin, K; Nguyen, MV; Pidcock, W; Sanville, B; Schivo, M; Sebat, C; Thompson, GR | 1 |
| Douedi, S; Miskoff, J | 1 |
| Berlin, DA; Gulick, RM; Martinez, FJ | 1 |
| Gupta, P; Kumar, A; Narasimha Kumar, GV; Prajapati, S; Sharma, M | 1 |
| Cameli, M; Cameli, P; Franchi, F; Mandoli, GE; Menci, D; Mondillo, S; Sciaccaluga, C; Sisti, N; Valente, S | 1 |
| Bos, LDJ; Brodie, D; Calfee, CS | 1 |
| Ali, K; Mallah, H; Maveddat, A; Nugent, K; Rao, S; Sherali, S | 1 |
| Ledford, H | 1 |
| Bebell, LM; Brigl, M; Matias, WR; Vaidya, A | 1 |
| Copaescu, A; Drewett, G; Gordon, CL; Holmes, NE; James, F; Mouhtouris, E; Smibert, OC; Trubiano, JA; Vogrin, S | 1 |
| Ahmed, M; Begum, SM; Islam, B; Islam, Z | 1 |
| Jing, BW; Lou, YH; Yang, XY; Zhu, YY | 1 |
| Fang, X; Frank, JA; Matthay, MA; McAuley, DF | 1 |
4 review(s) available for adenosine monophosphate and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Severe Covid-19.
Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antiviral Agents; Brain; COVID-19; COVID-19 Testing; Dexamethasone; Dyspnea; Humans; Lung; Male; Middle Aged; Patient Acuity; Radiography, Thoracic; Respiration, Artificial; Respiratory Distress Syndrome; SARS-CoV-2; Tomography, X-Ray Computed | 2020 |
COVID-19 and the burning issue of drug interaction: never forget the ECG.
Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Antiviral Agents; Arrhythmias, Cardiac; Chloroquine; COVID-19 Drug Treatment; Drug Combinations; Drug Interactions; Electrocardiography; Heart Failure; Humans; Hydroxychloroquine; Hypoxia; Inflammation; Long QT Syndrome; Lopinavir; Myocarditis; Myocardium; Precipitating Factors; Receptors, Interleukin-6; Respiratory Distress Syndrome; Ribavirin; Ritonavir; SARS-CoV-2; Water-Electrolyte Imbalance | 2021 |
Severe Acute Respiratory Distress Syndrome Secondary to Coronavirus 2 (SARS-CoV-2).
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Humans; Immunization, Passive; Lung; Pandemics; Pneumonia, Viral; Positive-Pressure Respiration; Respiratory Distress Syndrome; SARS-CoV-2; United States | 2020 |
Severe acute myopathy following SARS-CoV-2 infection: a case report and review of recent literature.
Topics: Adenosine Monophosphate; Adult; Alanine; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiviral Agents; COVID-19; Creatine Kinase; Critical Illness; Dexamethasone; Electromyography; Glucocorticoids; Heparin, Low-Molecular-Weight; Humans; Intensive Care Units; Magnetic Resonance Imaging; Male; Methicillin-Resistant Staphylococcus aureus; Muscle, Skeletal; Muscular Diseases; Neural Conduction; Pulmonary Embolism; Quadriplegia; Respiration, Artificial; Respiratory Distress Syndrome; SARS-CoV-2; Severity of Illness Index; Staphylococcal Infections; Ventilator Weaning | 2021 |
1 trial(s) available for adenosine monophosphate and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Randomized, double-blind, controlled trial of human anti-LIGHT monoclonal antibody in COVID-19 acute respiratory distress syndrome.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Adult; Alanine; Antibodies, Monoclonal; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Disease-Free Survival; Double-Blind Method; Female; Humans; Male; Middle Aged; Respiratory Distress Syndrome; SARS-CoV-2; Survival Rate; Tumor Necrosis Factor Ligand Superfamily Member 14 | 2022 |
10 other study(ies) available for adenosine monophosphate and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Case Report: Severe SARS-CoV-2 Infection Treated with Remdesivir in a Patient with ESRD.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Kidney Failure, Chronic; Male; Middle Aged; Respiratory Distress Syndrome; SARS-CoV-2 | 2022 |
A Community-transmitted Case of Severe Acute Respiratory Distress Syndrome (SARS) Due to SARS-CoV-2 in the United States.
Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Community-Acquired Infections; COVID-19; COVID-19 Drug Treatment; Female; Humans; Middle Aged; Respiratory Distress Syndrome; Risk Factors; Shock, Septic; Thorax; Tomography, X-Ray Computed; Treatment Outcome; United States | 2020 |
Novel coronavirus 2019 (COVID-19): A case report and review of treatments.
Topics: Adenosine Monophosphate; Aged; Alanine; Antimalarials; Antiviral Agents; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Fatal Outcome; Female; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; SARS-CoV-2 | 2020 |
An update on novel COVID-19 pandemic: a battle between humans and virus.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; RNA, Viral; SARS-CoV-2; Survival Analysis | 2020 |
Severe COVID-19 Infections-Knowledge Gained and Remaining Questions.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Critical Care; Critical Care Outcomes; Extracorporeal Membrane Oxygenation; Hospital Mortality; Humans; Patient Positioning; Prone Position; Respiration, Artificial; Respiratory Distress Syndrome; SARS-CoV-2; Severity of Illness Index | 2021 |
Why do COVID death rates seem to be falling?
Topics: Adenosine Monophosphate; Age Distribution; Age Factors; Aged; Aged, 80 and over; Alanine; Antibodies, Monoclonal, Humanized; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Dexamethasone; Humans; Immunization, Passive; Intensive Care Units; Oxygen; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; SARS-CoV-2; Time Factors; Ventilators, Mechanical | 2020 |
A Patient with Fever and Dyspnea.
Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antiviral Agents; Combined Modality Therapy; COVID-19; Dexamethasone; Diagnosis, Differential; Dyspnea; Female; Fever; Humans; Leukocyte Count; Lung; Middle Aged; Myalgia; Nasopharynx; Oxygen; Radiography, Thoracic; Respiration, Artificial; Respiratory Distress Syndrome; SARS-CoV-2 | 2020 |
The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy-A Prospective Longitudinal Study.
Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Anti-Inflammatory Agents; Antiviral Agents; Bacteremia; Biomarkers; C-Reactive Protein; Cohort Studies; Comorbidity; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Female; Humans; Interleukin-6; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Respiratory Distress Syndrome; Severity of Illness Index; Staphylococcal Infections | 2021 |
[Diagnostic effect of bronchoalveolar lavage in early lung injury caused by enterogenic infection in rat].
Topics: Adenosine Monophosphate; Animals; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Endotoxins; Female; Male; Oligopeptides; Phospholipases A; Phospholipases A2; Random Allocation; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Tumor Necrosis Factor-alpha | 2004 |
Clinically relevant concentrations of beta2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury.
Topics: Adenosine Monophosphate; Adrenergic beta-Agonists; Albuterol; Animals; Extravascular Lung Water; Pulmonary Alveoli; Pulmonary Edema; Pulmonary Gas Exchange; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Salmeterol Xinafoate; Stereoisomerism | 2004 |